Joined Today: 14

COLY Coley Pharmaceutical Group,, Stock Message Board

All Messages

COLY Message Board Home | Join The COLY Group |

#6: Coley Pharmaceutical Group to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
FastFun	November 27, 2007 10:09:01 PM
WELLESLEY, Mass., Nov. 26 /PRNewswire-FirstCall/ -- Coley Pharmaceutical Group, Inc. (Nasdaq: COLY), today announced that Robert L. Bratzler, Ph.D., President & Chief Executive... view message ignore post recommend post

#5: Pfizer to Acquire Coley Pharmaceutical Group
FastFun	November 27, 2007 10:08:14 PM
Acquisition Will Expand Pfizer’s Investment in Vaccines, Broaden Scope of Research in a Number of Key Therapeutic Areas Pfizer Inc (NYSE: PFE) announced today it has entered into an... view message ignore post recommend post

#4: Coley Pharmaceutical Group to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
FastFun	November 27, 2007 10:07:36 PM
WELLESLEY, Mass., Oct. 31 /PRNewswire-FirstCall/ -- Coley Pharmaceutical Group, Inc. (Nasdaq: COLY), today announced that Robert L. Bratzler, Ph.D., Coley's President and Chief Executive... view message ignore post recommend post

#3: Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
FastFun	November 27, 2007 10:06:45 PM
- Pfizer-funded Screening Agreement Fuels Discovery of Novel Compounds, Complements Clinical Development Initiatives with PF-3512676 - WELLESLEY, Mass., Oct. 30 /PRNewswire-FirstCall/ --... view message ignore post recommend post

#2: Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
FastFun	November 27, 2007 10:06:04 PM
-- CPG 52364, Coley's First Orally-Available, Small Molecule Drug Candidate, Enters Phase I Clinical Development -- WELLESLEY, Mass., Oct. 29 /PRNewswire-FirstCall/ -- Coley... view message ignore post recommend post

#1: COLY, Coley Pharmaceutical Group Reports First Quarter Financial Results
Jason	May 29, 2007 03:36:45 PM
Coley Pharmaceutical Group, Inc. (Nasdaq: COLY Forum Stocks), a biopharmaceutical company discovering and developing a novel class of drug candidates known as TLR Therapeutics(TM), today reported... view message ignore post recommend post

Group Home | Login if you want to post a message